Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Genomica AB
AB
In liquidation
Org 5569193278
Manufacture of irradiation, electromedical and electrotherapeutic equipment
·
NACE 2660
Est. 2013 · 13 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of irradiation, electromedical and electrotherapeutic equipment
/
Genomica AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
15M
11M
7M
4M
0M
2018: 5M
5M
2018
2019: 6M (+20% vs 2018)
6M
+20%
2019
2020: 12M (+100% vs 2019)
12M
+100%
2020
2021: 4M (-67% vs 2020)
4M
-67%
2021
2022: 1M (-75% vs 2021)
1M
-75%
2022
EBITDA
SEK millions
4M
3M
2M
1M
0M
2018: 0M
0M
2018
2019: 1M
1M
2019
2020: 3M (+200% vs 2019)
3M
+200%
2020
2021: 0M (-100% vs 2020)
0M
-100%
2021
2022: 1M
1M
2022
Income statement
SEK thousands
Item
2022
2021
2020
2019
2018
Revenue
1 471
3 998
12 436
6 009
4 917
Staff expenses
—
—
—
—
—
EBITDA
791
−60
3 062
1 089
−358
Depreciation & amort.
−0
−0
−228
−186
−230
EBIT
791
−60
2 834
903
−588
Net financials
−4
—
—
−2
−1
Profit before tax
1 311
−4
2 254
901
−588
Tax
−276
−0
−372
−0
−0
Net profit
1 035
−4
1 882
901
−588
Balance sheet
SEK thousands
Item
2022
2021
2020
2019
2018
Total assets
4 269
3 898
5 121
1 488
1 654
Equity
3 961
2 925
2 930
1 048
146
Long-term debt
0
0
0
0
0
Short-term debt
308
448
1 611
441
1 508
Total debt
308
448
1 611
441
1 508
Financial ratios
5-year trend
EBITDA margin
53.8%
This company
15.8%
Market median
This company
Market median
241% above market
2018
2022
Equity ratio
92.8%
This company
38.2%
Market median
This company
Market median
143% above market
2018
2022
Return on equity
26.1%
This company
18.4%
Market median
This company
Market median
42% above market
2018
2022
Net profit margin
70.4%
This company
8.1%
Market median
This company
Market median
769% above market
2018
2022
Asset turnover
0.34×
This company
1.12×
Market median
This company
Market median
70% below market
2018
2022
Debt / equity
0.08×
This company
0.62×
Market median
This company
Market median
87% below market
2018
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
More on Genomica AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
